论文信息 - Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab in the first-line setting.

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab in the first-line setting.

3587 Background: Currently, no definitive biomarkers have been identified to predict outcome with the use of bevacizumab (Bev) in cancer patients.The aim of this study was to evaluate the associati...